EVGN
Price
$1.34
Change
-$0.02 (-1.47%)
Updated
Jul 3 closing price
Capitalization
11.56M
32 days until earnings call
INSM
Price
$98.24
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
18.58B
26 days until earnings call
Interact to see
Advertisement

EVGN vs INSM

Header iconEVGN vs INSM Comparison
Open Charts EVGN vs INSMBanner chart's image
Evogene
Price$1.34
Change-$0.02 (-1.47%)
Volume$44.79K
Capitalization11.56M
Insmed
Price$98.24
Change-$0.00 (-0.00%)
Volume$33
Capitalization18.58B
EVGN vs INSM Comparison Chart in %
Loading...
EVGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EVGN vs. INSM commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVGN is a Hold and INSM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (EVGN: $1.34 vs. INSM: $98.24)
Brand notoriety: EVGN and INSM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EVGN: 2% vs. INSM: 0%
Market capitalization -- EVGN: $11.56M vs. INSM: $18.58B
EVGN [@Biotechnology] is valued at $11.56M. INSM’s [@Biotechnology] market capitalization is $18.58B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVGN’s FA Score shows that 0 FA rating(s) are green whileINSM’s FA Score has 1 green FA rating(s).

  • EVGN’s FA Score: 0 green, 5 red.
  • INSM’s FA Score: 1 green, 4 red.
According to our system of comparison, INSM is a better buy in the long-term than EVGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVGN’s TA Score shows that 5 TA indicator(s) are bullish while INSM’s TA Score has 6 bullish TA indicator(s).

  • EVGN’s TA Score: 5 bullish, 5 bearish.
  • INSM’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, INSM is a better buy in the short-term than EVGN.

Price Growth

EVGN (@Biotechnology) experienced а +4.69% price change this week, while INSM (@Biotechnology) price change was -6.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

EVGN is expected to report earnings on Aug 06, 2025.

INSM is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INSM($18.6B) has a higher market cap than EVGN($11.6M). INSM YTD gains are higher at: 42.294 vs. EVGN (-28.342). EVGN has higher annual earnings (EBITDA): -14.42M vs. INSM (-917.87M). INSM has more cash in the bank: 1.2B vs. EVGN (9.85M). EVGN has less debt than INSM: EVGN (13M) vs INSM (1.14B). INSM has higher revenues than EVGN: INSM (381M) vs EVGN (6.77M).
EVGNINSMEVGN / INSM
Capitalization11.6M18.6B0%
EBITDA-14.42M-917.87M2%
Gain YTD-28.34242.294-67%
P/E Ratio0.30N/A-
Revenue6.77M381M2%
Total Cash9.85M1.2B1%
Total Debt13M1.14B1%
FUNDAMENTALS RATINGS
EVGN vs INSM: Fundamental Ratings
EVGN
INSM
OUTLOOK RATING
1..100
9716
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
96
Overvalued
PROFIT vs RISK RATING
1..100
10012
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6137
P/E GROWTH RATING
1..100
91100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EVGN's Valuation (36) in the Biotechnology industry is somewhat better than the same rating for INSM (96). This means that EVGN’s stock grew somewhat faster than INSM’s over the last 12 months.

INSM's Profit vs Risk Rating (12) in the Biotechnology industry is significantly better than the same rating for EVGN (100). This means that INSM’s stock grew significantly faster than EVGN’s over the last 12 months.

INSM's SMR Rating (100) in the Biotechnology industry is in the same range as EVGN (100). This means that INSM’s stock grew similarly to EVGN’s over the last 12 months.

INSM's Price Growth Rating (37) in the Biotechnology industry is in the same range as EVGN (61). This means that INSM’s stock grew similarly to EVGN’s over the last 12 months.

EVGN's P/E Growth Rating (91) in the Biotechnology industry is in the same range as INSM (100). This means that EVGN’s stock grew similarly to INSM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EVGNINSM
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 12 days ago
69%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 8 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
EVGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DFSU39.960.30
+0.76%
Dimensional US Sustainability Core 1 ETF
HERD40.52N/A
N/A
Pacer Cash Cows Fund of Funds ETF
SDCP25.92N/A
N/A
Virtus Newfleet Short Dur Cor Pls Bd ETF
SPSK18.24-0.01
-0.05%
SP Funds Dow Jones Global Sukuk ETF
EVSD51.07-0.03
-0.07%
Eaton Vance Short Duration Income ETF

INSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSM has been closely correlated with THAR. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if INSM jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
N/A
THAR - INSM
74%
Closely correlated
+2.20%
KRYS - INSM
42%
Loosely correlated
+1.22%
ROIV - INSM
42%
Loosely correlated
+0.18%
CRNX - INSM
41%
Loosely correlated
+1.22%
RNA - INSM
40%
Loosely correlated
-0.65%
More